The National Cancer Institute says that over the next decade, the number of cancer survivors is expected to grow by a third to almost 18 million. That means several million more cancer survivors will be walking into primary care offices seeking help with health issues that may stem from their cancer treatment. Now more than ever, it’s important that all health care providers (HCPs) understand the long-term and late effects of cancer and its treatment and how to best manage follow-up care. And it is crucial as the cancer survivorship population continues to grow that health care providers understand recent advances in technology and how to apply them in their practice to best help cancer survivors.
Course Overview: Español
Survivorship and Employment
Professor, Biomedical Informatics & Rehabilitation
The University of Texas Health Science Center at Houston
Summary: “Cancer Survivors are discriminated against in employment. We don’t know when it happens. We don’t know whether it’s going to happen, but it does happen,” says Lex Frieden, Professor of Biomedical Informatics and Rehabilitation at The University of Texas Health Science Center at Houston. In this lecture, “Survivorship and Employment,” Mr. Frieden discusses issues that cancer survivors face related to employment, advises providers on legislative and program supports available to survivors, and apprises providers about how to help survivors transition back to work smoothly.
Summary and Learning Objectives: Español
Hematologic Malignancies: Survivorship Health
Presenter: Alma Rodriguez, M.D.
Vice President of Medical Affairs
Summary: “What we have been observing over the last few decades is that for unexplained reasons it appears that non-Hodgkin lymphomas are increasing in incidence,” says M. Alma Rodriguez, M.D., Vice President of Medical Affairs, Office of the Executive Vice President, Physician-in-Chief, Professor of Lymphoma/Myeloma at The University of Texas MD Anderson Cancer Center. Rodriguez discusses the clinical course and survivorship implications for those with chronic hematologic malignancies versus those with aggressive diagnoses. She reviews the common systemic treatment strategies and identifies secondary long-term potential health problems related to the treatment and disease categories. Rodriguez also describes essential components of survivorship care for patients with hematologic malignancies.
Summary and Learning Objectives: Español
Critical Elements in Designing a Cancer Survivorship Program
Presenter: Paula Lewis-Patterson, DNP, MSN, NEA-BC
Office of Cancer Survivorship
Summary: Three critical factors contributing to the success of The University
of Texas MD Anderson Cancer Center’s cancer survivorship program, which includes 12 survivorship clinics, are “commitment from leadership, dedicated
survivorship resources, and stakeholder buy-in” says Dr. Paula Lewis-Patterson, Executive Director of the Office of Cancer Survivorship. In Dr. Lewis-Patterson’s presentation, “Critical Elements in Designing a Cancer Survivorship Program,” she defines cancer survivorship care and discusses changing trends in cancer survivorship, including commentary on why those trends are so important. She discusses critical components of survivorship care and details the importance of planning, implementation, metrics, and evaluation to cancer survivorship programming. Dr. Lewis-Patterson also discusses diverse models of survivorship programs and suggests how survivorship care can be structured in other institutions.
Cardiac Issues in Cancer Survivors
Presenter: Jean-Bernard Durand, M.D.
Associate Professor, Cardiology
Summary: “Cardiologists at The University of Texas MD Anderson Cancer Center provide roughly 3,000 outpatient and inpatient consults per year,” says Jean-Bernard Durand, M.D., an Associate Professor in the Department of Cardiology at The University of Texas MD Anderson Cancer Center. “We have over 1,000 patients with a diagnosis of heart failure. We perform over 16,000 echocardiograms and over 60,000 EKGs per year. We know the importance of recognizing cardiac problems very early on in the course of treatment of a cancer patient, rather than waiting until severe symptoms occur from toxicities of treatments. Thus, a lot of our conversations deal with the issue of how to prevent cardiac complications from occurring, as well as how to treat them.”
In his lecture, “Cardiac Issues in Cancer Survivors,” Durand addresses
practitioners who see patients with cancer and cancer survivors who have or may develop cardiac problems. Durand discusses differential diagnosis of acute left ventricular systolic dysfunction to evaluate cardiomyopathy of unknown etiology(CUE). He presents practice-based evidence, in addition to evidence-based medicine, that underpins his discussion of the importance of diagnostic testing. Durand reviews standard therapy for acute left ventricular systolic dysfunction and discusses the role of re-challenge of chemotherapy. He states that maximizing the potential of new cancer therapies requires identifying cardiotoxicity up front and early and treating it aggressively, as well as appropriately tracking and improving quality of care. Durand concludes by emphasizing the importance of collaboration with cardio-oncologists in the prevention, management, and treatment of cancer patients at high risk of
cardiovascular complications prior to, during, and long after their cancer treatment.
For further information or assistance, to provide feedback on this web site, or to request a specific professional oncology education topic, please e-mail Professional Oncology Education.